Wells Fargo’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Wells Fargo’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,119	Closed	-$31.8K	–	7830
2023 Q3	$31.8K	Sell	3,119 -2,499	-44%	-$19K	﹤0.01%	5402
2023 Q2	$26.4K	Buy	5,618 +2,936	+109%	+$13.5K	﹤0.01%	5653
2023 Q1	$12.4K	Buy	+2,682	New	+$11.8K	﹤0.01%	5789
2022 Q4	–	Sell	-242	Closed	-$1K	–	7825
2022 Q3	$1K	Sell	242 -99	-29%	-$498	﹤0.01%	6533
2022 Q2	$2K	Sell	341 -1,128	-77%	-$6.86K	﹤0.01%	6421
2022 Q1	$9K	Sell	1,469 -2,674	-65%	-$14.4K	﹤0.01%	6329
2021 Q4	$26K	Buy	+4,143	New	+$32.4K	﹤0.01%	6248

Wells Fargo's THRN Position: Q4 2023 in Review

Wells Fargo sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 3,119 shares — an estimated $31.8K sold.

Wells Fargo first reported a position in THRN in Q4 2021 and held it in 7 quarters. The position peaked at $31.8K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Wells Fargo reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 3,119 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $31.8K.
Wells Fargo first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Wells Fargo's Thorne Healthtech, Inc. Common Stock position peaked at $31.8K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.